In breast cancer, OIP5-AS1 was found significantly up-regulated and functioned as an oncogene via regulating cell malignant phenotypes [14], whereas the role of OIP5-AS1 in trastuzumab resistance in breast cancer still needs to be explored. The gene discussed is OIP5; the disease is breast carcinoma.